Skip to main content

Gene Network Sciences Wins $1.6M SBIR Grant to Develop VisualHeart Software

NEW YORK (GenomeWeb News) — Gene Network Sciences today said it has won a $1.6-million Small Business Innovation Research grant from the National Heart, Lung and Blood Association to help develop its VisualHeart software.
The software is a cardiac-modeling platform designed to use data on the molecular effects of drugs to "determine proarrythmic markers and mechanism of action."
Under the terms of the three-year grant, GNS will collaborate on research with Cornell University and with the Masonic Medical Research Laboratory.
GNS vice president of research Jeffrey Fox said the company's technology uses a "model agnostic approach" that enables researchers to translate between different systems, which Fox said will allow pharmaceutical companies to save money by focusing their "data collection efforts."
GNS said that IBM has contributed use of its Blue Gene supercomputing
products to the project.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.